JUUL Busy Producing Research

Posted 6th May 2021 by Dave Cross
Following its submission of the Premarket Tobacco Product Application (PMTA) to
America’s Food & Drug Administration (FDA) last summer, JUUL Labs focussed on completing a swathe of peer-reviewed research. The company has just published 11 studies in a monograph edition of the American Journal of Health Behavior (AJHB).

JUUL Labs told POTV that it is, “committed to working collaboratively with regulators, policymakers, public health leaders, and other stakeholders as we work to reset the category and company and strive to earn a license to operate in society. This includes scientific exchange with these stakeholders as we advance a science and evidence-based dialogue.”

Its PMTA to the FDA contained:

  • Over 110 original scientific studies
  • Over 125,000 pages of data

The information included detail of how JUUL pods impact on individual users, how they help to help adult smokers switch to vaping, and the net-population impact on public health.

It says: “Following the PMTA filing last summer, our Regulatory team turned their attention to publishing some of the key research underlying our application through peer-reviewed manuscripts. While FDA is ultimately responsible for analysing the scientific evidence about our products and making a determination regarding their public health impact, we also appreciate that the scientific and public health community have an interest in better understanding the harm reduction potential of vapor products, including JUUL products.”

The AJHB monograph (1), “focuses on the centrepiece of our behavioural research program: the Adult JUUL User Switching and Smoking Trajectories (ADJUSST) study, which sought to understand patterns of tobacco product use among adult JUUL Product purchasers. The ADJUSST study collected data on over 55,000 current, former, and never smokers who bought a JUUL Starter Kit for the first time and followed them over the course of a year.”

Premier Ecigs

The company say the articles represent “a significant portion of our research portfolio and address many of the key topics of public health concern and interest.” It hopes the publication furthers discussion about the harm reduction potential of its vape products in reducing the number of Americans killed each year from smoking.

Below is a full list of articles in the monograph publication:

  • Prevalence of ENDS and JUUL Use, by Smoking Status, in National Samples of Young Adults and Older Adults in the U.S.
  • The Adult JUUL Switching and Smoking Trajectories (ADJUSST) Study: Methods and Analysis of Loss-to-Follow-Up
  • Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System
  • Dual Use of Cigarettes and JUUL: Trajectory and Cigarette Consumption
  • Switching away from Cigarette Smoking with JUUL: Populations of Special Interest
  • Cigarette Smoking Trajectories in Adult Former Smokers Using the JUUL System
  • Smoking Trajectories of Adult Never Smokers 12 Months after First Purchase of a JUUL Starter Kit
  • Transitions in Smoking among Adults Newly Purchasing the JUUL System
  • Changes in Dependence as Smokers Switch from Cigarettes to JUUL in Two Nicotine Concentrations
  • Improving Retailer Compliance for Tobacco Purchases: Pilot Study Findings Modeling the Population Health Impact of ENDS in the U.S.


  1. JUUL’s Research - https://ajhb.org/wp-content/uploads/2021/04/AJHB_JUUL_Special_Issue.pdf

 Dave Cross
Article by Dave Cross
Freelance writer, physicist, karateka, dog walker
B+MOR Vape